A multi-centre registry trial is testing the use of a new imaging tracer for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.

St. Joseph's Hospital - 

Prostate cancer can be elusive.

Wayne Smith’s journey with prostate cancer began 16 years ago when his family physician noticed increasing levels of prostate specific antigen (PSA) in his blood. PSA is a protein expressed by the prostate. A blood test is used to monitor levels of the protein as a screening tool for prostate cancer.

New technology will improve surgery outcomes and reduce time in the operating room for patients with breast cancer

St. Joseph's Hospital - 

Researchers at Lawson Health Research Institute (Lawson) are developing a hand-held photoacoustic imaging probe to be used during breast conserving surgery to quickly and accurately verify if all cancerous tissue has been removed.

Surgeons currently do not have real-time technology to guide tumour removal during surgery.

Using current tools, there is a 20 per cent chance that cancerous cells will be left behind, risking recurrence and repeat surgery.